Anatomic TSA vs RTSA for Glenohumeral Arthritis
NCT: NCT04629391 · RECRUITING
Brief Summary
There are no published prospective studies that compared 2-year functional outcomes of RTSA and anatomic TSA for the treatment of primary glenohumeral osteoarthritis with intact rotator cuffs and no excessive glenoid retroversion. The primary goal of our prospective randomized study is to determine whether RTSA have at least as good results as anatomic TSA (non-inferiority), in patients with glenohumeral osteoarthritis, without rotator cuff tears nor significant glenoid retroversion.
Frequently Asked Questions
What is Anatomic TSA vs RTSA for Glenohumeral Arthritis?
Anatomic TSA vs RTSA for Glenohumeral Arthritis is a clinical trial registered under NCT04629391. Current status: RECRUITING.
What is the status of NCT04629391?
The current status of NCT04629391 (Anatomic TSA vs RTSA for Glenohumeral Arthritis) is: RECRUITING.
When did Anatomic TSA vs RTSA for Glenohumeral Arthritis start?
Anatomic TSA vs RTSA for Glenohumeral Arthritis started on 2020-09-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.